Detailansicht

Wissensnetz

Person

Kai Berner (1991-)

Arzt

Name	Kai Berner
Zeit	1991- (Lebensdaten)
Ort	Deutschland
Geschlecht	männlich
Beruf	Arzt (charakteristischer Beruf)
Weitere Angaben	Arzt in der Klinik für Frauenheilkunde, Universitätsklinikum Freiburg
Quelle	FreiDok plus
Datensatztyp	Person
GND-Nummer	1208231413
Datensatz-ID	1208231413
Beteiligt an alle anzeigen Long non‑coding RNA signatures in breast cancer: Properties as biomarkers? Real-world data analysis of CDK4/6 inhibitor therapy - a patient-centric single center study In vitro microRNA expression profile alterations under CDK4/6 therapy in breast cancer Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case–control study Anticarcinogenic effects of odorant substances citral, citrathal R and cyclovertal on breast cancer in vitro Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case–control study Transitioning the molecular tumor board from proof of concept to clinical routine: a german single-center analysis Circulating non‑coding RNA‑biomarker potential in neoadjuvant chemotherapy of triple negative breast cancer? Endoxifen and fulvestrant regulate estrogen-receptor [alpha] and related DEADbox proteins Circulating microRNAs as potential diagnostic biomarkers in ovarian cancer

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Kai Berner (1991-)

Long non‑coding RNA signatures in breast cancer: Properties as biomarkers?

Real-world data analysis of CDK4/6 inhibitor therapy - a patient-centric single center study

In vitro microRNA expression profile alterations under CDK4/6 therapy in breast cancer

Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case–control study

Anticarcinogenic effects of odorant substances citral, citrathal R and cyclovertal on breast cancer in vitro

Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case–control study

Transitioning the molecular tumor board from proof of concept to clinical routine: a german single-center analysis

Circulating non‑coding RNA‑biomarker potential in neoadjuvant chemotherapy of triple negative breast cancer?

Endoxifen and fulvestrant regulate estrogen-receptor [alpha] and related DEADbox proteins

Circulating microRNAs as potential diagnostic biomarkers in ovarian cancer